Herpes Cure Advocacy confirms a national strategy and strategic plan for Herpes Simplex Virus Types 1 and 2 in the approved House FY 2022 budget.
On page 245, the House FY budget report reads:
National Strategy for Herpes Simplex Virus (HSV), Types 1 and 2.—The Committee recognizes that an estimated 1 in 3 Americans has Herpes, and that most Americans with HSV do not have symptoms and do not realize they have it. In light of the national prioritization of ending the HIV/AIDS epidemic, maternal health, neonatal health, and the all-time high of STIs, the Committee urges the Assistant Secretary for Health to develop a national strategy and strategic plan for the treatment and prevention of HSV types 1 and 2.
Herpes Cure Advocacy thanks the following people for their support in this effort: Dr. Phil Chan, Dr. Larry Corey, Dr. Robert Golden, Mr. Agustin Fernandez, Dr. Harvey Friedman, Dr. Jeffrey Klausner, Dr. Keith Jerome, Dr. Ina Park, Dr. Hilary Reno, Dr. Gary Richwald, Dr. Sten Vermund, and Ms. Terry Warren.
The national strategy is intended to outline strategic imperatives for the treatment and prevention of HSV in America. A strategic plan will consequently outline actionable objectives and tasks in order to accomplish these strategic goals.
While there is no budget assignment on the house side, HCA advocates and stakeholders continue to advocate the senate LHHS subcommittee for a fiscal budget for this project. Advocates say, “We are confident that the broad support for this public health imperative will ensure a fiscal budget assignment as the appropriations process is ongoing on the senate side. A project with no budget is too low priority – we want to guarantee this work gets done in 2022.”
About Herpes Cure Advocacy
Herpes Cure Advocacy (HCA) is a grassroots, membership-based international advocacy organization of 7,000+ members with a goal of cure and prevention for Herpes Simplex Virus types 1 and 2.
HCA works with patient advocates , HSV and clinical experts, and organizational stakeholders to help chart the path towards HSV treatment and prevention.
Want to join our advocate army? We need help. We’re looking to build our network of advocates, including patients and HSV field experts internationally. If you want to join the fight for Herpes treatment and prevention, please contact us.
2 thoughts on “National Strategy for Herpes: A DHHS Strategic Plan in House FY 2022 Budget”